Works matching IS 03407004 AND DT 2011 AND VI 60 AND IP 10

Results: 14

Low molecular weight hyaluronan preconditioning of tumor-pulsed dendritic cells increases their migratory ability and induces immunity against murine colorectal carcinoma.

Published in:

Cancer Immunology, Immunotherapy, 2011, v. 60, n. 10, p. 1383, doi. 10.1007/s00262-011-1036-0

By:

Alaniz, Laura;
Rizzo, Manglio;
Garcia, Mariana;
Piccioni, Flavia;
Aquino, Jorge;
Malvicini, Mariana;
Atorrasagasti, Catalina;
Bayo, Juan;
Echeverria, Itziar;
Sarobe, Pablo;
Mazzolini, Guillermo

Publication type:

Article

Immuno-cell therapy with antecedent surgery has superior actuarial survival to immuno-cell therapy without antecedent surgery for advanced cancers.

Published in:

Cancer Immunology, Immunotherapy, 2011, v. 60, n. 10, p. 1397, doi. 10.1007/s00262-011-1044-0

By:

Shindo, Goki;
Endo, Takayoshi;
Onda, Masamitsu;
Miyamoto, Yoju;
Kaneko, Toru;
Goto, Shigenori

Publication type:

Article

Ectonucleotidases CD39 and CD73 on OvCA cells are potent adenosine-generating enzymes responsible for adenosine receptor 2A-dependent suppression of T cell function and NK cell cytotoxicity.

Published in:

Cancer Immunology, Immunotherapy, 2011, v. 60, n. 10, p. 1405, doi. 10.1007/s00262-011-1040-4

By:

Häusler, Sebastian;
Montalbán del Barrio, Itsaso;
Strohschein, Jenny;
Anoop Chandran, P.;
Engel, Jörg;
Hönig, Arnd;
Ossadnik, Monika;
Horn, Evi;
Fischer, Birgitt;
Krockenberger, Mathias;
Heuer, Stefan;
Seida, Ahmed;
Junker, Markus;
Kneitz, Hermann;
Kloor, Doris;
Klotz, Karl-Norbert;
Dietl, Johannes;
Wischhusen, Jörg

Publication type:

Article

Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13.

Published in:

Cancer Immunology, Immunotherapy, 2011, v. 60, n. 10, p. 1419, doi. 10.1007/s00262-011-1028-0

By:

Gabitass, Rachel;
Annels, Nicola;
Stocken, Deborah;
Pandha, Hardev;
Middleton, Gary

Publication type:

Article

Involvement of damage-associated molecular patterns in tumor response to photodynamic therapy: surface expression of calreticulin and high-mobility group box-1 release.

Published in:

Cancer Immunology, Immunotherapy, 2011, v. 60, n. 10, p. 1431, doi. 10.1007/s00262-011-1047-x

By:

Korbelik, Mladen;
Zhang, Wei;
Merchant, Soroush

Publication type:

Article

An ADP ribosylation factor-GTPase activating protein negatively regulates the production of proinflammatory mediators in response to lipopolysaccharide.

Published in:

Cancer Immunology, Immunotherapy, 2011, v. 60, n. 10, p. 1439, doi. 10.1007/s00262-011-1048-9

By:

Haque, Abedul;
Noman, Abu;
Koide, Naoki;
Odkhuu, Erdenezaya;
Naiki, Yoshikazu;
Hashimoto, Shoji;
Komatsu, Takayuki;
Yoshida, Tomoaki;
Yokochi, Takashi

Publication type:

Article

Pilot trial of interleukin-2 and zoledronic acid to augment γδ T cells as treatment for patients with refractory renal cell carcinoma.

Published in:

Cancer Immunology, Immunotherapy, 2011, v. 60, n. 10, p. 1447, doi. 10.1007/s00262-011-1049-8

By:

Lang, Joshua;
Kaikobad, Mahazarin;
Wallace, Marianne;
Staab, Mary;
Horvath, Dorothea;
Wilding, George;
Liu, Glenn;
Eickhoff, Jens;
McNeel, Douglas;
Malkovsky, Miroslav

Publication type:

Article

Myxoma virus combined with rapamycin treatment enhances adoptive T cell therapy for murine melanoma brain tumors.

Published in:

Cancer Immunology, Immunotherapy, 2011, v. 60, n. 10, p. 1461, doi. 10.1007/s00262-011-1045-z

By:

Thomas, Diana;
Doty, Rosalinda;
Tosic, Vesna;
Liu, Jia;
Kranz, David;
McFadden, Grant;
MacNeill, Amy;
Roy, Edward

Publication type:

Article

Th17 and Th17-stimulated CD8 T cells play a distinct role in Th17-induced preventive and therapeutic antitumor immunity.

Published in:

Cancer Immunology, Immunotherapy, 2011, v. 60, n. 10, p. 1473, doi. 10.1007/s00262-011-1054-y

By:

Ankathatti Munegowda, Manjunatha;
Deng, Yulin;
Mulligan, Sean;
Xiang, Jim

Publication type:

Article

Serum levels of cytoplasmic melanoma-associated antigen at diagnosis may predict clinical relapse in neuroblastoma patients.

Published in:

Cancer Immunology, Immunotherapy, 2011, v. 60, n. 10, p. 1485, doi. 10.1007/s00262-011-1052-0

By:

Morandi, Fabio;
Corrias, Maria;
Levreri, Isabella;
Scaruffi, Paola;
Raffaghello, Lizzia;
Carlini, Barbara;
Bocca, Paola;
Prigione, Ignazia;
Stigliani, Sara;
Amoroso, Loredana;
Ferrone, Soldano;
Pistoia, Vito

Publication type:

Article

Dendritic cells combining with cytokine-induced killer cells synergize chemotherapy in patients with late-stage non-small cell lung cancer.

Published in:

Cancer Immunology, Immunotherapy, 2011, v. 60, n. 10, p. 1497, doi. 10.1007/s00262-011-1060-0

By:

Zhong, Runbo;
Teng, Jiajun;
Han, Baohui;
Zhong, Hua

Publication type:

Article

The potential role of thioredoxin 1 and CD30 systems as multiple pathway targets and biomarkers in tumor therapy.

Published in:

Cancer Immunology, Immunotherapy, 2011, v. 60, n. 10, p. 1373, doi. 10.1007/s00262-011-1068-5

By:

Berghella, Anna;
Pellegrini, Patrizia;
Del Beato, Tiziana;
Ciccone, Fabiana;
Contasta, Ida

Publication type:

Article

The n3-polyunsaturated fatty acid docosahexaenoic acid induces immunogenic cell death in human cancer cell lines via pre-apoptotic calreticulin exposure.

Published in:

Cancer Immunology, Immunotherapy, 2011, v. 60, n. 10, p. 1503, doi. 10.1007/s00262-011-1074-7

By:

Molinari, Romina;
D'Eliseo, Donatella;
Manzi, Laura;
Zolla, Lello;
Velotti, Francesca;
Merendino, Nicolò

Publication type:

Article

Combination of targeted therapy and immunotherapy in melanoma.

Published in:

Cancer Immunology, Immunotherapy, 2011, v. 60, n. 10, p. 1359, doi. 10.1007/s00262-011-1079-2

By:

Blank, Christian;
Hooijkaas, Anna;
Haanen, John;
Schumacher, Ton

Publication type:

Article